MAP Pharmaceuticals was acquired by Allergan on March 22, 2013
life science Company

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 179 acquisitions of life science companies in 2013, including 20 acquisitions by private equity firms, and 159 by strategics.

MAP Pharmaceuticals, Inc.

2400 Bayshore Parkway, Suite 200,
Mountain View, California 94043
United States,
(650) 386-3100
www.mappharma.com

MAP Pharmaceuticals, Inc. is a specialty pharmaceutical company developing innovative therapies and inhalation delivery platforms to treat a broad spectrum of respiratory and systemic diseases.

Life Science M&A - Last 3 Years

MAP Pharmaceuticals was acquired by Allergan on March 22, 2013.

Join Mergr to view this profile - and discover more life science acquisitions of companies like MAP Pharmaceuticals.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.7K Private Equity Firms
  • 131K M&A Transactions
  • 140K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.